Dr Reddys Laboratories, an integrated global pharmaceutical company, has announced its entry into the hair serum market with the launch of MINTOP PRO Procapil Hair Therapy. "MINTOP PRO comes from the same branch of business that manufactures launches MINTOP PRO the number one dermatologist recommended brand in the country," it said.
Studies revealed that Androgenetic alopecia (AGA) is one of the most common reasons for dermatological consultation, the company said. "This type of hair loss has been reported in 58% of middle-age men and 19% of women and there have been rapid advancements in understanding the pathophysiology of AGA over the last few years," it added.
Shares of the company declined Rs 151.3, or 3.6%, to settle at Rs 4,056.15. The total volume of shares traded was 12,395 at the BSE (Friday).